Literature DB >> 10959904

Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.

W C Wang1, D M Gallagher, C H Pegelow, E C Wright, E P Vichinsky, M R Abboud, F G Moser, R J Adams.   

Abstract

PURPOSE: To compare the results of standardized magnetic resonance imaging (MRI) of the brain and transcranial Doppler (TCD) ultrasonography of cerebral arteries in school-aged children with sickle cell disease to determine the correlation between these two different neurodiagnostic tests. PATIENTS AND METHODS: Data were analyzed from 78 children with sickle cell disease (mean age 11 yrs) who participated in both the Cooperative Study of Sickle Cell Disease (CSSCD) and the Stroke Prevention Trial in Sickle Cell Anemia (STOP). Patients who had experienced an overt stroke were excluded. MRI findings were classified as normal or "silent infarct." Results of TCD were classified as normal, conditional, or abnormal, based on the time-averaged maximum mean flow velocity in the proximal middle cerebral and distal internal carotid arteries.
RESULTS: Of 61 patients who had a normal MRI examination, 11 (18%) had either conditional (5 patients) or abnormal (6 patients) TCD results. Among 17 patients in whom silent infarction was seen on MRI, only 5 (29%) had a conditional (1 patient) or abnormal (4 patients) TCD velocity. Thus, discordant results were seen in 23 patients: 12 in which the TCD result was normal and the MRI abnormal; 11 in which the TCD velocity was elevated and the MRI normal.
CONCLUSIONS: Abnormal TCD and MRI examinations reveal different aspects of the pathophysiology of central nervous system (CNS) injury in sickle cell disease and are often discordant. Although TCD abnormality is predictive of overt stroke, the lack of concordance between TCD and MRI findings suggests a need to develop more sensitive and specific indicators of early CNS pathology, such as neuropsychometric testing and positron-emission tomography (PET) scans, and to obtain more information about microvascular pathologic processes that may affect CNS function.

Entities:  

Mesh:

Year:  2000        PMID: 10959904     DOI: 10.1097/00043426-200007000-00010

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  15 in total

1.  Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.

Authors:  Miguel R Abboud; Eunsil Yim; Khaled M Musallam; Robert J Adams
Journal:  Blood       Date:  2011-06-01       Impact factor: 22.113

Review 2.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease.

Authors:  Henrietta Enninful-Eghan; Reneé H Moore; Rebecca Ichord; Kim Smith-Whitley; Janet L Kwiatkowski
Journal:  J Pediatr       Date:  2010-09       Impact factor: 4.406

Review 4.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

5.  Noninvasive optical assessment of resting-state cerebral blood flow in children with sickle cell disease.

Authors:  Seung Yup Lee; Kyle R Cowdrick; Bharat Sanders; Eashani Sathialingam; Courtney E McCracken; Wilbur A Lam; Clinton H Joiner; Erin M Buckley
Journal:  Neurophotonics       Date:  2019-08-19       Impact factor: 3.593

6.  Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.

Authors:  Sandra L Samarron; Joshua W Miller; Anthony T Cheung; Peter C Chen; Xin Lin; Theodore Zwerdling; Ted Wun; Ralph Green
Journal:  Br J Haematol       Date:  2020-04-19       Impact factor: 6.998

Review 7.  Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

Authors:  Michael R DeBaun; F Daniel Armstrong; Robert C McKinstry; Russell E Ware; Elliot Vichinsky; Fenella J Kirkham
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

8.  Silent infarcts in young children with sickle cell disease.

Authors:  Janet L Kwiatkowski; Robert A Zimmerman; Avrum N Pollock; Wendy Seto; Kim Smith-Whitley; Justine Shults; Anne Blackwood-Chirchir; Kwaku Ohene-Frempong
Journal:  Br J Haematol       Date:  2009-06-04       Impact factor: 6.998

9.  CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.

Authors:  Manoelle Kossorotoff; Mariane De Montalembert; Valentine Brousse; Dominique Lasne; Emmanuel Curis; David M Smadja; Romaric Lacroix; Sebastien Bertil; Elodie Masson; Isabelle Desguerre; Damien Bonnet; Pascale Gaussem
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

10.  Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia.

Authors:  Melanie E Fields; Kristin P Guilliams; Dustin Ragan; Michael M Binkley; Amy Mirro; Slim Fellah; Monica L Hulbert; Morey Blinder; Cihat Eldeniz; Katie Vo; Joshua S Shimony; Yasheng Chen; Robert C McKinstry; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal:  Blood       Date:  2019-03-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.